Is this your brand? Sign in to claim ownership.

Sign in to claim this brand

Abbott Point of Care Inc.

US

Last updated September 17, 2026

What Abbott Point of Care Inc. makes

The company manufactures point-of-care diagnostic devices for clinical chemistry, blood gas analysis, and electrolyte testing, including reagent cartridges and control materials for troponin I, sodium, potassium, and human chorionic gonadotropin beta-core fragment assays. Their products also include portable blood gas and haemoximetry analysers designed for rapid, bedside patient monitoring.

These devices are regulated under FDA classifications as Class I and Class II, with authorisations recorded via 510(k) clearances and the Unique Device Identifier (UDI) system. The company is based in the United States.

Written from this company's registered devices by an AI model, and not verified by a human reviewer.

Frequently asked questions

What types of medical devices does Abbott Point of Care Inc. manufacture?

Abbott Point of Care Inc. specialises in point-of-care diagnostic devices used in clinical settings. Their products include analysers for blood gas, haemoximetry, and electrolyte testing, as well as reagent cartridges and control materials for assays like troponin I, sodium, potassium, and human chorionic gonadotropin beta-core fragment. These devices are designed for rapid, bedside patient monitoring, ensuring quick results for critical clinical decisions.

Where is Abbott Point of Care Inc. based, and how does that affect its regulatory oversight?

Abbott Point of Care Inc. is based in the United States, which means its devices fall under the regulatory authority of the FDA. The company’s products are classified as either Class I or Class II devices, depending on their risk level, and their authorisations are tracked through FDA processes like 510(k) clearances and the Unique Device Identifier (UDI) system. This ensures compliance with U.S. medical device regulations.

Which regulatory registries or databases list Abbott Point of Care Inc.’s devices?

Abbott Point of Care Inc.’s devices are recorded in the FDA’s 510(k) clearance database and the Unique Device Identifier (UDI) system. These registries track the authorisation status of Class I and Class II devices, ensuring transparency in their regulatory compliance. The UDI system, in particular, helps identify and trace specific devices throughout their lifecycle.

How are Abbott Point of Care Inc.’s devices classified under FDA regulations?

Abbott Point of Care Inc.’s devices are classified as either Class I or Class II under FDA regulations. Class I devices generally pose minimal risk and may require general controls, while Class II devices involve a higher level of risk and require special controls to ensure safety and effectiveness. The classification determines the regulatory pathway and oversight required for each product.

What kinds of tests or measurements do Abbott Point of Care Inc.’s point-of-care devices perform?

Abbott Point of Care Inc.’s devices perform a range of critical tests, including blood gas analysis (such as oxygen and carbon dioxide levels), haemoximetry (measuring oxygen saturation), electrolyte testing (like sodium and potassium levels), and clinical chemistry assays (e.g., troponin I for heart-related markers). Some devices also include controls for specific assays, ensuring accuracy and reliability in point-of-care settings.

AI-generated from registry data and not verified by a human reviewer.

Information

Country
US
Address
400 College Road East, Princeton, NJ, 08540
Website
—
LinkedIn
—
Facebook
—
Email
—
Phone
—
PRRC Contact
—
EUDAMED SRN
—
FDA FEI Number
2245578
DUNS Number
—

Catalogue (144)

Page 2 of 3
DeviceModel / ReferenceRegistriesClassStatus
i-STAT 02R60-01
FDA UDI
Class IIActive
i-STAT 02R60-80
FDA UDI
Class IIActive
i-STAT 06P17-09
FDA UDI
Class IActive
i-STAT 04J48-20
FDA UDI
Class IIActive
i-STAT 06F14-01
FDA UDI
Class IActive
i-STAT 09P31-26
FDA UDI
Class IIActive
i-STAT 09P31-25
FDA UDI
Class IIActive
i-STAT PTplus Control Level 1 06P17-17
FDA UDI
Class IIActive
i-STAT 06F13-01
FDA UDI
Class IActive
i-STAT 06P17-24
FDA UDI
Class IActive
i-STAT 03P75-85
FDA UDI
Class IIActive
i-STAT 06P17-02
FDA UDI
Class IActive
i-STAT 06F12-01
FDA UDI
Class IActive
i-STAT 06F24-20
FDA UDI
Class IActive
i-STAT 04P75-43
FDA UDI
Class IIActive
i-STAT 06P17-14
FDA UDI
Class IIActive
i-STAT 03P75-88
FDA UDI
Class IIActive
i-STAT 02R60-82
FDA UDI
Class IIActive
i-STAT 03P75-63
FDA UDI
Class IIActive
i-STAT 03P75-86
FDA UDI
Class IIActive
i-STAT 04P75-01R
FDA UDI
Class IIActive
i-STAT 03P82-25
FDA UDI
Class IIUnknown
i-STAT 05P59-04
FDA UDI
Class IActive
i-STAT 03P75-06
FDA UDI
Class IIActive
i-STAT 03P75-90
FDA UDI
Class IIActive
i-STAT 03P83-25
FDA UDI
Class IIActive
i-STAT 03P75-62
FDA UDI
Class IIActive
i-STAT 03P75-54
FDA UDI
Class IIActive
i-STAT 04P75-31
FDA UDI
Class IIActive
i-STAT 03P75-89
FDA UDI
Class IIActive
i-STAT 03P76-25
FDA UDI
Class IIActive
i-STAT hs-TnI Calibration Verification, Levels 1-3 06P17-20
FDA UDI
Class IActive
i-STAT 06P17-13
FDA UDI
Class IIActive
i-STAT hs-TnI Control Level 3 06P17-23
FDA UDI
Class IActive
i-STAT 03P75-59
FDA UDI
Class IIActive
i-STAT 02R60-05
FDA UDI
Class IIActive
i-STAT hs-TnI cartridge 09P81-25
FDA UDI
Class IIActive
i-STAT 06P17-16
FDA UDI
Class IIActive
i-STAT 03P80-25
FDA UDI
Class IIActive
i-STAT 03P78-50
FDA UDI
Class IIUnknown
i-STAT 03P75-01
FDA UDI
Class IIActive
i-STAT 03P75-81
FDA UDI
Class IIActive
i-STAT 04P75-03
FDA UDI
Class IIActive
i-STAT 06F24-16
FDA UDI
Class IUnknown
i-STAT 03P85-25
FDA UDI
Class IActive
i-STAT 06P17-05
FDA UDI
Class IActive
i-STAT 06P17-07
FDA UDI
Class IActive
i-STAT 04P75-01
FDA UDI
Class IIActive
i-STAT 03P75-57
FDA UDI
Class IIActive
i-STAT 03P75-53
FDA UDI
Class IIActive

Related Companies

Authorised Representatives

No authorised representatives on record.

Importers

Not available yet.

Notified Bodies

Not available yet.

Authorities

Not available yet.

FDA Recalls (77)

Recalls reported by this firm to the FDA. Listed at company level — FDA recall records don't identify a specific catalogue device.

Abbott Point of Care Inc. has initiated 77 recall records between September 25, 2006, and April 1, 2026, with statuses recorded as open, classified, or terminated. The reasons cited include potential inaccuracies in test results for various cartridges (e.g., cardiac troponin I, PT/INR, potassium, and CO₂ measurements), battery overheating risks, software-related functionality issues (e.g., data updates and reset defaults), difficulties filling certain cartridge lots, and lack of regulatory clearance for updated sample types. Some recalls involved product documentation updates or hardware compatibility concerns with peripheral devices.

AI-generated summary of the recall records listed below. It describes what the records state and is not an assessment of this manufacturer.

DateRecall No.ClassStatusReason
Apr 1, 2026Z-1999-2026—open, classified

Approximately 7.6% of cartridges from specific i-STAT EG7+ (list number 03P76-25), i-STAT EG6+ (list number 03P77-25) and i-STAT G3+ (list number 03P78-26) cartridge lots in the U.S. marketplace may report higher than expected PCO2 and lower than expected pH results due to a manufacturing issue. A falsely high pCO2 together with a falsely low pH makes the blood gas appear as if the patient is in severe respiratory acidosis. If the clinician believes the values are real, it may trigger unnecessary or even harmful interventions such as unnecessary ventilator changes, unnecessary medications, potential harm from overcorrection, or delays in identifying true problems.

Apr 1, 2026Z-2000-2026—open, classified

Approximately 7.6% of cartridges from specific i-STAT EG7+ (list number 03P76-25), i-STAT EG6+ (list number 03P77-25) and i-STAT G3+ (list number 03P78-26) cartridge lots in the U.S. marketplace may report higher than expected PCO2 and lower than expected pH results due to a manufacturing issue. A falsely high pCO2 together with a falsely low pH makes the blood gas appear as if the patient is in severe respiratory acidosis. If the clinician believes the values are real, it may trigger unnecessary or even harmful interventions such as unnecessary ventilator changes, unnecessary medications, potential harm from overcorrection, or delays in identifying true problems.

Apr 1, 2026Z-2001-2026—open, classified

Approximately 7.6% of cartridges from specific i-STAT EG7+ (list number 03P76-25), i-STAT EG6+ (list number 03P77-25) and i-STAT G3+ (list number 03P78-26) cartridge lots in the U.S. marketplace may report higher than expected PCO2 and lower than expected pH results due to a manufacturing issue. A falsely high pCO2 together with a falsely low pH makes the blood gas appear as if the patient is in severe respiratory acidosis. If the clinician believes the values are real, it may trigger unnecessary or even harmful interventions such as unnecessary ventilator changes, unnecessary medications, potential harm from overcorrection, or delays in identifying true problems.

Aug 21, 2025Z-2585-2025—open, classified

Lack of a 510(k) premarket clearance for the i-STAT CG8+, EG7+ and EG6+ cartridges to reflect updated sample type for potassium and ionized calcium and measurement ranges for pH and PO2.

Aug 21, 2025Z-2582-2025—open, classified

Lack of a 510(k) premarket clearance for the i-STAT CG4+ cartridge to reflect updated sample type for lactate and measurement ranges for pH and PO2.

Aug 21, 2025Z-2584-2025—open, classified

Lack of a 510(k) premarket clearance for the i-STAT CG8+, EG7+ and EG6+ cartridges to reflect updated sample type for potassium and ionized calcium and measurement ranges for pH and PO2.

Aug 21, 2025Z-2583-2025—open, classified

Lack of a 510(k) premarket clearance for the i-STAT CG8+, EG7+ and EG6+ cartridges to reflect updated sample type for potassium and ionized calcium and measurement ranges for pH and PO2.

Dec 22, 2020Z-0880-2021—terminated

Ionized calcium test on some i-STAT CG8+ and EG7+ cartridges may exhibit higher than expected reported results when stored at room temperature (18 to 30C) for periods of time in excess of 3 days for lot numbers *20100 to *20339 and 7 days for lot numbers *20340 and above Where * = lot letter A, K, L, M, N, W or Y.

Dec 22, 2020Z-0881-2021—terminated

Ionized calcium test on some i-STAT CG8+ and EG7+ cartridges may exhibit higher than expected reported results when stored at room temperature (18 to 30C) for periods of time in excess of 3 days for lot numbers *20100 to *20339 and 7 days for lot numbers *20340 and above Where * = lot letter A, K, L, M, N, W or Y.

Jan 15, 2020Z-1262-2020—terminated

The I-STAT BLUE CHEM8+ and CG4+ cartridges are not FDA cleared and do not have CLIA waived status. CLIA recognizes two types of laboratory tests: waived and non-waived. Different CLIA standards apply to waived and non-waived tests as well as the facilities that perform these types of tests. The i-STAT CHEM8+ cartridge contains nine measured assays (sodium, potassium, chloride, blood urea nitrogen (BUN), ionized calcium, TCO2, glucose, creatinine and hematocrit) and is categorized as a CLIA waived test for venous whole blood samples, meaning this cartridge could be used in a facility with a CLIA Certificate of Waiver as a waived test.

Jan 15, 2020Z-1263-2020—terminated

The I-STAT BLUE CHEM8+ and CG4+ cartridges are not FDA cleared and do not have CLIA waived status. CLIA recognizes two types of laboratory tests: waived and non-waived. Different CLIA standards apply to waived and non-waived tests as well as the facilities that perform these types of tests. The i-STAT CHEM8+ cartridge contains nine measured assays (sodium, potassium, chloride, blood urea nitrogen (BUN), ionized calcium, TCO2, glucose, creatinine and hematocrit) and is categorized as a CLIA waived test for venous whole blood samples, meaning this cartridge could be used in a facility with a CLIA Certificate of Waiver as a waived test.

Jan 14, 2020Z-1265-2020—terminated

Marketed without a 510(k). Abbott Point of Care has determined that it does not have sufficient clinical evidence to fully characterize the performance of the blue i-STAT G3+ cartridges and therefore will no longer distribute the i-STAT G3+ (blue) cartridge in the United States as of May 1, 2020.

Oct 16, 2019Z-0761-2020—terminated

i-STAT cTnI blue cartridges may generate a higher than expected number of quality check codes. The observed rate of quality check codes could be in the 3 to 5% range.

Sep 13, 2018Z-0615-2019—terminated

Inaccurate potassium results may be generated. When testing with control fluid and/or patient samples with low or reference range potassium concentration, elevated potassium results may be generated. When testing with samples with a high concentration of potassium, decreased potassium results may be generated

Sep 12, 2017Z-0926-2018—terminated

Issues resulting from upgrade to software version 2.8: (1) Location, operator, stored patient lists will not update, and (2) Customized Reference Ranges, Action Ranges, and Custom Reportable Ranges are reset to factory default values. No erroneous results are generated as a result of this issue.

Jun 15, 2015Z-2361-2015—terminated

Certain lots of PT/INR cartridges may generate a higher than typical number of PT/INR star outs potentially delaying the generation of patient results for PT/INR.

Jan 1, 2014Z-1306-2014—terminated

Abbott Point of Care has determined that some individual patient results generated with the i-STAT G3+ cartridge lot N13183 have the potential to exhibit incorrectly elevated PCO2 and depressed pH results.

Oct 28, 2013Z-0451-2014—terminated

Abbott Point of Care Inc (APOC) has determined that i-Stat PT/INR cartridges have the potential to exhibit incorrectly elevated INR.

Jul 19, 2012Z-0192-2013—terminated

Abbott Point of Care (APOC) has determined that for the Cliniqa Liquid QC Cardiac Marker Control for i-STAT Level 1 (List #06F12-09; Lot Number 071039); i-STAT Level 2 (List #06F12-10; Lot Number 081039); and i-STAT Level 3 (List #06F12-11; Lot Number 091039) results may be generated below the lower value assignment range for some vials.

Mar 7, 2012Z-2237-2012—terminated

Abbott Point of Care has determined that i-Stat CTNL cartridges have the potential to exhibit incorrectly elevated cardiac troponin I results. This recall was expanded on July 19 2012 to include additional information regarding user documentation.

Mar 1, 2012Z-2157-2012—terminated

The i-STAT PT/INR cartridges have the potential to exhibit incorrectly elevated results.

Feb 1, 2012Z-2169-2012—terminated

The frequency of suppressed results for i-Stat cTnl, BNP and CK-MP cartridges is affected by atmospheric pressure.

Feb 1, 2012Z-2171-2012—terminated

The frequency of suppressed results for i-Stat cTnl, BNP and CK-MP cartridges is affected by atmospheric pressure.

Feb 1, 2012Z-2170-2012—terminated

The frequency of suppressed results for i-Stat cTnl, BNP and CK-MP cartridges is affected by atmospheric pressure.

Sep 29, 2011Z-0180-2012—terminated

i-Stat cTnI cartridges beginning with letter "T" may exhibit a higher than expected variability in reported results. This increased variability may result in falsely elevated or falsely depressed results.

Sep 8, 2011Z-1978-2012—terminated

Some i-Stat Analyzers become uncomfortably hot to touch in the are of the battery. This is a recall extension.

Sep 8, 2011Z-1975-2012—terminated

Some i-Stat Analyzers become uncomfortably hot to touch in the are of the battery. This is a recall extension.

Sep 8, 2011Z-1977-2012—terminated

Some i-Stat Analyzers become uncomfortably hot to touch in the are of the battery. This is a recall extension.

Sep 8, 2011Z-1976-2012—terminated

Some i-Stat Analyzers become uncomfortably hot to touch in the are of the battery. This is a recall extension.

Sep 8, 2011Z-1973-2012—terminated

Some i-Stat Analyzers become uncomfortably hot to touch in the are of the battery. This is a recall extension.

Sep 8, 2011Z-1974-2012—terminated

Some i-Stat Analyzers become uncomfortably hot to touch in the are of the battery. This is a recall extension.

Feb 15, 2011Z-2022-2011—terminated

i-STAT CHEM 8+ cartridge may generate false results for sodium, chloride and hematocrit.

Jan 1, 2011Z-2133-2012—terminated

i-Stat EG7 cartridges may generate falsely depressed PCO2 results for samples above 26 mm hg when stored at room temperature for four weeks or longer.

Dec 17, 2010Z-1864-2011—terminated

Presence of CO2 in the head space of the vial can result in the generation of high results in Cardiac Marker Control Level 1, 2, and 3 which is used along with the Cardiac Marker Control Calibration Verification Set.

Dec 17, 2010Z-1863-2011—terminated

Presence of CO2 in the head space of the vial can result in the generation of high results in Cardiac Marker Control Level 1, 2, and 3 which is used along with the Cardiac Marker Control Calibration Verification Set.

Dec 3, 2010Z-1341-2011—terminated

Celite ACT cartridges have increased numbers of values outside the accepted allowable error.

Oct 6, 2010Z-0400-2011—terminated

Certain lots of i-STAT Celite ACT and Kaolin ACT cartridges may be difficult to fill or will not fill when attempting to transfer blood to the sample entry port of the cartridge.

Oct 6, 2010Z-0399-2011—terminated

Certain lots of i-STAT Celite ACT and Kaolin ACT cartridges may be difficult to fill or will not fill when attempting to transfer blood to the sample entry port of the cartridge.

Sep 20, 2010Z-0594-2011—terminated

i-STAT Analyzers batteries may overheat due to a circuitry failure, resulting in the analyzer becoming uncomfortably hot in the area of the battery component.

Sep 20, 2010Z-0597-2011—terminated

i-STAT Analyzers batteries may overheat due to a circuitry failure, resulting in the analyzer becoming uncomfortably hot in the area of the battery component.

Sep 20, 2010Z-0598-2011—terminated

i-STAT Analyzers batteries may overheat due to a circuitry failure, resulting in the analyzer becoming uncomfortably hot in the area of the battery component.

Sep 20, 2010Z-0595-2011—terminated

i-STAT Analyzers batteries may overheat due to a circuitry failure, resulting in the analyzer becoming uncomfortably hot in the area of the battery component.

Sep 20, 2010Z-0596-2011—terminated

i-STAT Analyzers batteries may overheat due to a circuitry failure, resulting in the analyzer becoming uncomfortably hot in the area of the battery component.

Sep 20, 2010Z-0593-2011—terminated

i-STAT Analyzers batteries may overheat due to a circuitry failure, resulting in the analyzer becoming uncomfortably hot in the area of the battery component.

Aug 20, 2010Z-2462-2010—terminated

Reliability issues associated with broken connection pins within the downloader that mate with the pins from the analyzer.

Aug 3, 2010Z-0930-2011—terminated

Two cartridge lots were identified that may generate falsely elevated PCO2 results.

Aug 3, 2010Z-1020-2011—terminated

Three i-STAT Level 2 Control Value Assignment Sheets and the i-STAT CLEW A20 Software System Manual Update CD contain the incorrect range for pCO2, BUN and Glucose for the i-STAT EC8+, 6+, EC4+, E3 and G cartridge types.

Aug 3, 2010Z-0929-2011—terminated

Two cartridge lots were identified that may generate falsely elevated PCO2 results.

May 5, 2010Z-1996-2010—terminated

A high mean bias (12-16%) was documented in 8 lots of i-STAT PT/INR cartridges. This may lead a clinician to believe that a patient is adequately anticoagulated when they are not. Inadequate anticoagluation therapy may be given and issues with clotting and/or thrombosis could occur. No reports of injury have been received.

Mar 17, 2010Z-0456-2011—terminated

The i-STAT CREA Cartridges may produce inaccurate (depressed) results at or near the end of the labeled expiry date when stored above 25 degrees for 2 weeks.

Feb 5, 2010Z-1793-2010—terminated

Abbott has determined that there is a dependence of the i-STAT Hct assay on the vertical pitch angle of the i-STAT Analyzer during the blood analysis cycle.

Feb 5, 2010Z-1791-2010—terminated

Abbott has determined that there is a dependence of the i-STAT Hct assay on the vertical pitch angle of the i-STAT Analyzer during the blood analysis cycle.

Feb 5, 2010Z-1798-2010—terminated

Abbott has determined that there is a dependence of the i-STAT Hct assay on the vertical pitch angle of the i-STAT Analyzer during the blood analysis cycle.

Feb 5, 2010Z-1797-2010—terminated

Abbott has determined that there is a dependence of the i-STAT Hct assay on the vertical pitch angle of the i-STAT Analyzer during the blood analysis cycle.

Feb 5, 2010Z-1794-2010—terminated

Abbott has determined that there is a dependence of the i-STAT Hct assay on the vertical pitch angle of the i-STAT Analyzer during the blood analysis cycle.

Feb 5, 2010Z-1795-2010—terminated

Abbott has determined that there is a dependence of the i-STAT Hct assay on the vertical pitch angle of the i-STAT Analyzer during the blood analysis cycle.

Feb 5, 2010Z-1796-2010—terminated

Abbott has determined that there is a dependence of the i-STAT Hct assay on the vertical pitch angle of the i-STAT Analyzer during the blood analysis cycle.

Feb 5, 2010Z-1792-2010—terminated

Abbott has determined that there is a dependence of the i-STAT Hct assay on the vertical pitch angle of the i-STAT Analyzer during the blood analysis cycle.

Nov 6, 2009Z-1133-2010—terminated

Some Martel Printers used with the i-STAT 1 system have the potential of being damaged due to the use or rechargeable battery packs that do not contain a fuse.

Sep 29, 2009Z-0865-2010—terminated

Abbott Point of Care has determined that it is possible under certain circumstances that some test records could have their status update messages mis-matched with another record, resulting in the incorrect patient name, order number of comment being included in the CDS test record only.

Sep 9, 2009Z-0812-2010—terminated

The storage temperature on the label on the side of the i-Stat Portable Clinical Analyzer shipping box does not match product specification.

Aug 18, 2009Z-0814-2010—terminated

Labeling discrepancy: The manual instruction state that the line should be flushed with 5 mL of saline and the first 5 mL of blood or six dead space volumes should be discarded. The Cartridge Test Information sheets that it should be 2 mL of blood - which is incorrect.

Aug 18, 2009Z-0813-2010—terminated

Labeling discrepancy: The manual instruction state that the line should be flushed with 5 mL of saline and the first 5 mL of blood or six dead space volumes should be discarded. The Cartridge Test Information sheets that it should be 2 mL of blood - which is incorrect.

Apr 22, 2009Z-2328-2009—terminated

It appears that the rechargeable battery pack is overheating with or without the presence of smoke.

Feb 23, 2009Z-1540-2009—terminated

Equipment problem: i-STAT cartridges were not properly sealed as the packaging system jammed, causing compromised seals.

Feb 23, 2009Z-1541-2009—terminated

Equipment problem: i-STAT cartridges were not properly sealed as the packaging system jammed, causing compromised seals.

Jan 1, 2008Z-0318-2011—terminated

i-Stat cartridges may not fill, cartridge labels or channels may appear discolored, cartridges may have fluid visible in the cartridge channel, and cartridge packaging may be distended.

Jan 1, 2008Z-0317-2011—terminated

i-Stat cartridges may not fill, cartridge labels or channels may appear discolored, cartridges may have fluid visible in the cartridge channel, and cartridge packaging may be distended.

Jan 1, 2008Z-0319-2011—terminated

i-Stat cartridges may not fill, cartridge labels or channels may appear discolored, cartridges may have fluid visible in the cartridge channel, and cartridge packaging may be distended.

Oct 18, 2007Z-0374-2008—terminated

Difficult to Close -- Certain lots of i-STAT cartridges are difficult to close, will not close or do not stay closed.

Oct 18, 2007Z-0372-2008—terminated

Difficult to Close -- Certain lots of i-STAT cartridges are difficult to close, will not close or do not stay closed.

Oct 18, 2007Z-0373-2008—terminated

Difficult to Close -- Certain lots of i-STAT cartridges are difficult to close, will not close or do not stay closed.

Oct 18, 2007Z-0375-2008—terminated

Difficult to Close -- Certain lots of i-STAT cartridges are difficult to close, will not close or do not stay closed.

Oct 18, 2007Z-0370-2008—terminated

Difficult to Close -- Certian lots of i-STAT cartridges are difficult to close, will not close or do not stay closed.

Oct 18, 2007Z-0371-2008—terminated

Difficult to Close -- Certain lots of i-STAT cartridges are difficult to close, will not close or do not stay closed.

Dec 12, 2006Z-0364-2007—terminated

Patients treated with the antibiotic CUBICIN can cause a concentration dependent false prolongation of prothrombin time (PT) and elevation of INR (International Normalized Ratio) when using the i-STAT PT/INR cartridges.

Sep 25, 2006Z-1621-2011—terminated

Certain lots of G3+ cartridges may be difficult to fill.